Coronary artery disease is one of the leading causes of death in the United States. The utility
of revascularization in patients presenting with acute coronary syndrome is well elucidated …

Introduction: Traditional and current perception for benefit of percutaneous coronary
intervention (PCI) is that patients with stable angina will obtain symptom relief as well as …

Purpose of review Coronary artery disease remains the most common cause of death
worldwide. In patients with biomarker-positive acute coronary syndrome, the combination of …

The treatment of patients with stable angina has three goals: 1) minimize or eliminate
ischemia (silent or symptomatic), 2) reduce morbidity, and 3) decrease mortality. Surgical …

Coronary artery disease is a chronic medical condition associated with high mortality and
morbidity. Among individuals with coronary artery disease, more than 50% have chronic …

The debate over coronary revascularization in stable ischemic heart disease has grown over
the past decade, sparked by the landmark COURAGE (Clinical Outcomes Utilizing …

For patients with chronic stable angina, several randomized trials have been performed
comparing medical management with surgery, medical management with angioplasty, and …

Defining optimal management of patients with stable coronary artery disease continues to
be a central area of debate. While it has been established that all patients with coronary …

Stable angina is a frequent problem and it impacts on outcomes and quality of life. The
treatment of stable angina includes a wide array of tools, including medical therapy and …

Coronary heart disease is a chronic, systemic disease with a wide range of associated
symptoms, clinical outcomes, and health care expenditure. Adverse events from coronary …